Research map: A retrospective single‐centre evaluation of systemic anticancer therapy near the end of life in patients with solid organ malignancies

Back to the article

Papers in this map

  1. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update · Bryan J. Schneider · 2021 · 2223 citations · Cited by this paper
  2. Methodological considerations in the pre‐implementation evaluation of AI ‐guided surgical antimicrobial prophylaxis · Areeha Mariam · 2026 · 1 citation · Related
  3. Palliative Care for Patients With Cancer: ASCO Guideline Update · Justin J. Sanders · 2024 · 355 citations · Cited by this paper
  4. Regulatory standardisation to improve the safety of continuous glucose monitoring systems in Australia and New Zealand: joint ADS / ADEA / ADIPS / ANZSPED / NZSSD statement · 2026 · Related
  5. Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines · Gregory Brian Crawford · 2021 · 214 citations · Cited by this paper
  6. Race‐neutral lung function equations and clinical interpretation in East Asian patients · 2026 · Related
  7. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study · Michael Wallington · 2016 · 193 citations · Cited by this paper
  8. Vitamin B6: too much, too little, too late? An analysis of sales trends in Australia from 2023 to 2025 · 2026 · Related
  9. Use of chemotherapy at end of life in oncology patients · Steven Chuan-Hao Kao · 2009 · 160 citations · Cited by this paper
  10. Assessing lung health disparities in Aboriginal Australians: inter‐community variation in spirometry pattern among adult Aboriginal people in rural and remote Australia · 2026 · Related
  11. Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline · Patrick Charles Stone · 2023 · 69 citations · Cited by this paper
  12. Improving primary aldosteronism diagnosis and treatment: outcomes from an endocrine hypertension service · 2026 · Related
  13. Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy · Nicholas Zdenkowski · 2013 · 63 citations · Cited by this paper
  14. Trustworthy artificial intelligence for rural health care · 2026 · Related
  15. Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care · Olivier Bylicki · 2019 · 51 citations · Cited by this paper
  16. Unravelling the paradox of smoking cessation in multimorbidity: the roles of polypharmacy and treatment burden · 2026 · Related
  17. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer · Yuhua Bao · 2017 · 45 citations · Cited by this paper
  18. Comparison of pharmacogenomic guidance in Australian prescribing resources and international pharmacogenomic guidelines · 2026 · Related
  19. The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis · Richa Shah · 2025 · 41 citations · Cited by this paper
  20. Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists · Yu Jung Kim · 2014 · 37 citations · Cited by this paper
  21. Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of Life · Fauzia Riaz · 2020 · 36 citations · Cited by this paper
  22. Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US · Daniel M. Kerekes · 2024 · 36 citations · Cited by this paper
  23. On-Target Side Effects of Targeted Therapeutics of Cancer · József Tı́már · 2022 · 33 citations · Cited by this paper
  24. Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors · Maureen Canavan · 2024 · 32 citations · Cited by this paper
  25. Systemic Anticancer Therapy at the End of Life—Changes in Usage Pattern in the Immunotherapy Era · Maureen Canavan · 2022 · 31 citations · Cited by this paper
  26. The end of life costs for Medicare patients with advanced ovarian cancer · Renata R. Urban · 2017 · 24 citations · Cited by this paper
  27. Systemic anticancer therapy in the last 30 days of life: Retrospective audit from an Australian Regional Cancer Centre · Peter J Gilbar · 2018 · 22 citations · Cited by this paper
  28. Mortality within 30 days of receiving systemic anti‐cancer therapy at a regional oncology unit: What have we learned? · Jaclyn Yoong · 2012 · 21 citations · Cited by this paper
  29. Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review · Teresa Geyer · 2023 · 21 citations · Cited by this paper
  30. Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre · Mike Nguyen · 2020 · 20 citations · Cited by this paper
  31. Clinical characteristics and prognostic factors of sepsis in patients with malignancy · Green Hong · 2025 · 18 citations · Cited by this paper
  32. Five‐year survival and clinical correlates among patients with advanced non‐small cell lung cancer, melanoma and renal cell carcinoma treated with immune check‐point inhibitors in Australian tertiary oncology centres · Lauren Julia Brown · 2022 · 16 citations · Cited by this paper
  33. Competing Risks of Cancer and Non-Cancer Mortality When Accompanied by Lifestyle-Related Factors—A Prospective Cohort Study in Middle-Aged and Older Adults · Paweł Macek · 2020 · 14 citations · Cited by this paper
  34. Comparing end‐of‐life care of hematologic malignancy versus solid tumor patients in a tertiary care center · Rachel Burstein · 2023 · 12 citations · Cited by this paper
  35. Early palliative care and its impact on end of life care · Daniel Monnery · 2024 · 7 citations · Cited by this paper
  36. Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With Cancer · Javaid Iqbal · 2025 · 7 citations · Cited by this paper
  37. Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019 · Charles Vesteghem · 2022 · 5 citations · Cited by this paper
  38. Anticancer therapy at end-of-life: A retrospective cohort study · Johnny Singh · 2024 · 5 citations · Cited by this paper
  39. Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer · Hayley Nicole Roberts · 2024 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)